It's About a Billion Lives Symposium 2024

Duration
4/26/24 8:00am - 12:30pm (4 and 1/2 hours)
Webinar Objectives
  1. Explain three key strategies to end today’s tobacco use epidemic
  2. Describe two different strategies to improve equity in tobacco use and improve tobacco cessation in diverse populations.

 

This year's Symposium will be held virtually and in-person at UCSF Robertson Auditorium (inside William J. Rutter Center), 1675 Owens Street, San Francisco, California

 

We are honored to have the following speakers presenting at this year’s Symposium:

Keynote Panel: Ending the Tobacco Epidemic:

  • Catherine O. Egbe, PhD Senior Specialist Scientist Mental health, Alcohol, Substance use and Tobacco Research Unit (MASTRU) South African Medical Research Council
  • Allison Chausmer Hoffman, PhD, MA, Deputy Director for Research Translation, CDC Office on Smoking and Health (OSH).
  • Charlene Le Fauve, PhD, Senior Advisor for Health Equity, FDA Center for Tobacco Products (CTP)
  • Ruth Malone, RN, PhD, UCSF Professor of Social and Behavioral Sciences
  • Moderator: Joanna Cohen, PhD, Bloomberg Professor of Disease Prevention, Chair, Department of Health, Behavior, and Society, Johns Hopkins University.

Presentations by Faculty and Postdoctoral Scholars:

  • "Evaluation of a contingency management smoking cessation intervention for people experiencing homelessness," Dian Gu, PhD, CTCRE Postdoctoral Scholar
  • "Unlocking Potential: Pharmacists' Key Role in Tobacco Cessation," Lisa Kroon, PharmD, Professor of Clinical Pharmacy, Co-Vice Dean of Clinical Innovation & Entrepreneurship, Assistant Chief Pharmacy Officer, Clinical Innovation, Education and Research, UCSF Health
  • "Social policies, health equity, and cannabis and tobacco-related outcomes: Mixed methods analyses" Morgan Philbin, PhD, MHS, Associate Professor of Medicine, Associate Director, UCSF Benioff Homelessness and Housing Initiative
  • "Toward an Analytical Framework of Tobacco-Related Misinformation: Findings from Twitter Data," Eileen Han, PhD, CTCRE Postdoctoral Scholar

Closing Remarks, Harold Collard, MD, MS, UCSF Vice Chancellor for Research

Instructions for CME/CE Credit

Up to four hours of FREE credit can be earned for a limited number of participants who join the LIVE session, in-person or online, on Friday, April 26, 2024. You will receive instructions on how to claim credit via the post webinar email.

ACCME Accreditation

The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

UCSF designates this live activity for a maximum of 4.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the webinar activity.

Advance Practice Registered Nurses and Registered Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 CreditTM issued by organizations accredited by the ACCME.

Physician Assistants: The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 CreditTM are acceptable for continuing medical education requirements for recertification.

California Pharmacists: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA category 1 CreditTM. If you are a pharmacist in another state, you should check with your state board for approval of this credit.

California Psychologists: The California Board of Psychology recognizes and accepts for continuing education credit courses that are provided by entities approved by the Accreditation Council for Continuing Medical Education (ACCME). AMA PRA Category 1 CreditTM is acceptable to meeting the CE requirements for the California Board of Psychology. Providers in other states should check with their state boards for acceptance of CME credit.

California Behavioral Science Professionals: University of California, San Francisco School of Medicine (UCSF) is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for behavioral health providers. UCSF maintains responsibility for this program/course and its content.

Course meets the qualifications for 4.0 hours of continuing education credit for LMFTs, LCSWs, LPCCs, and/or LEPs as required by the California Board of Behavioral Sciences. Provider # 64239.

ACCREDITATION FOR CALIFORNIA ADDICTION COUNSELORS

The UCSF office of continuing medical education is accredited by the California Consortium of Addiction Programs and Professionals (CCAPP), to provide continuing education credit for California addiction counselors. UCSF designates this live, virtual activity, for a maximum of 4.0 CCAPP credits. Addiction counselors should claim only the credit commensurate with the extent of their participation in the activity. Provider number: 7-20-322-0724.

Disclosures

This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

All speakers, planning committee members and reviewers have disclosed they have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Catherine Bonniot, Christine Cheng, Brian Clark, Joanna Cohen, PhD, Catherine O. Egbe, PhD, Dian Gu, PhD, Eileen Han, PhD, Allison Chausmer Hoffman, PhD, MA, Lisa Kroon, PharmD, Charlene Le Fauve, PhD, Pamela Ling, MD, MPH, Ruth Malone, RN, PhD,  Jennifer Matekuare, Ma Krisanta Pamatmat, MPH, CHES, Morgan Philbin, PhD, MHS, and Maya Vijayaraghavan, MD.